Clinical Trials Directory

Trials / Unknown

UnknownNCT03680547

Nephropathy in Patients With Sickle Cell Disease

Pattern of Sickle Cell Nephropathy in Patients With Sickle Cell Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
25 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
5 Months – 18 Years
Healthy volunteers
Not accepted

Summary

There are some diseases that give rise to diverse renal manifestations as does sickle cell disease

Detailed description

Such involvement adversely affects virtually all major physiological processes in the kidney, and leads to complications that are common and chronic on the one hand (such as impaired urinary concentrating ability), and those that are rare and uniformly fatal on the other (such as renal medullary carcinoma) This steady adverse renal sequelae shortens the average lifespan of patients with SCD. Proteinuria and a reduced glomerular filtration rate are risk factors associated with increased mortality among those patients with approximately 16-18% of overall mortality in this patient group is due to kidney disease. Once end stage renal disease is reached, the mortality of patients who are on haemodialysis and have SCD is increased severalfold relative to the mortality of patients who are on haemodialysis but do not have SCD. Thus,although the average lifespan of patients with SCD has increased during recent decades owing to improved management of complications outside the kidney,kidney disease contributes substantially to the still increased mortality in SCD.

Conditions

Interventions

TypeNameDescription
OTHERpatient with sickle cell diseaseassess degree of renal affection in patientswith sickle cell disease attending Assuit university Children hospital by estimating some predictors of glomerular and tubular dysfunction.

Timeline

Start date
2020-05-01
Primary completion
2020-05-30
Completion
2021-01-01
First posted
2018-09-21
Last updated
2019-11-29

Source: ClinicalTrials.gov record NCT03680547. Inclusion in this directory is not an endorsement.